Patent application number | Description | Published |
20080312257 | Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists - The present invention is directed to novel bicyclic triazolopyrimidine compounds of Formula (I) or a form thereof: | 12-18-2008 |
20090036409 | Novel inhibitors of chymase - The present invention is directed to a compound of formula (I), | 02-05-2009 |
20090068246 | COLLAGEN-RELATED PEPTIDES AND USES THEREOF - The present invention relates to a collagen-related polypeptide (CRP) having hydrophobic amino acid groups at the N- and C-termini capable of non-covalent self-assembly into collagen mimetic triple helices and fibrils thereof and the synthesis, methods of use and compositions thereof. | 03-12-2009 |
20090093515 | Substituted pyrroline kinase inhibitors - The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors and methods for treating or ameliorating a kinase or dual-kinase mediated disorder. | 04-09-2009 |
20090093634 | Substituted pyrroline kinase inhibitors - The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors and methods for treating or ameliorating a kinase or dual-kinase mediated disorder. | 04-09-2009 |
20090124804 | Enantioselective process for preparing a substituted alkanoic acid - The present invention is directed to a process for enantioselectively preparing substituted piperidine alkanoic acid integrin antagonist compounds. | 05-14-2009 |
20090163527 | Spiropiperidines for use as tryptase inhibitors - The present invention is directed to a compound of Formula (I): | 06-25-2009 |
20090176806 | SUBSTITUTED PYRROLINE KINASE INHIBITORS - The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder. | 07-09-2009 |
20090181982 | SUBSTITUTED PYRROLINE KINASE INHIBITORS - The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder. | 07-16-2009 |
20090299034 | Collagen-related peptides - The present invention relates to a collagen-related polypeptide (CRP) having hydrophobic amino acid groups at the N- and C-termini capable of non-covalent self-assembly into collagen mimetic triple helices and fibrils thereof and the synthesis, methods of use and compositions thereof. | 12-03-2009 |
20100029616 | UROTENSIN II RECEPTOR ANTAGONISTS - The present invention is directed to compounds of formula (I) | 02-04-2010 |
20100048513 | Novel inhibitors of chymase - The present invention is directed to a compound of formula (I), | 02-25-2010 |
20100240650 | SUBSTITUTED PYRROLINES AS KINASE INHIBITORS - The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder. | 09-23-2010 |
20110136824 | UROTENSIN II RECEPTOR ANTAGONISTS - The invention is directed to Urotensin II antagonists. More specifically, the present invention relates to certain novel compounds, methods for preparing compounds, compositions, intermediates and derivatives thereof and methods for treating Urotensin-II mediated disorders. Pharmaceutical and veterinary compositions and methods of treating cardiovascular disorders and various other disease states or conditions using compounds of the invention are also described. | 06-09-2011 |
20120022022 | NOVEL INHIBITORS OF CHYMASE - The present invention is directed to a compound of formula (I), | 01-26-2012 |
20120165327 | SPIROPIPERIDINES FOR USE AS TRYPTASE INHIBITORS - The present invention is directed to a compound of Formula (I): | 06-28-2012 |
20120214817 | UROTENSIN II RECEPTOR ANTAGONISTS - The invention is directed to Urotensin II antagonists. More specifically, the present invention relates to certain novel compounds, methods for preparing compounds, compositions, intermediates and derivatives thereof and methods for treating Urotensin-II mediated disorders. Pharmaceutical and veterinary compositions and methods of treating cardiovascular disorders and various other disease states or conditions using compounds of the invention are also described. | 08-23-2012 |